October 10, 2025
Headlines

Women Leadership

Alosant Secures Major Series A Funding Led by Greg Avis, Poised for Proptech Expansion with New Leadership Appointments

Editor05 mins

Alosant, a trailblazer in customer experience technology for master-planned communities, proudly announces the completion of its Series A funding round, spearheaded by Greg Avis, co-founder and former Managing Director of Summit Partners. This pivotal development, combined with strategic leadership appointments, positions Alosant for significant growth and innovation in the proptech sector. Greg Avis, now Managing…

Read More

Brightflow SAS Secures €16.5M for Revolutionary Minimally Invasive Heart Failure Treatment

Editor05 mins

In a significant leap forward for cardiovascular care, Brightflow SAS has successfully raised €16.5 million in Series A funding. This impressive round of equity investment is set to propel the company’s groundbreaking efforts in developing a minimally invasive solution for end-stage heart failure. Based in France, Brightflow SAS is at the forefront of innovation in…

Read More

TippingPoint Biosciences Receives Groundbreaking Funding to Pioneer Cure for Rare Pediatric Brain Tumor

Editor07 mins

In a significant stride towards revolutionizing treatments for one of the most challenging pediatric brain tumors, TippingPoint Biosciences has announced the successful closure of pre-seed investments. This funding round has garnered support from renowned organizations, including the Pediatric Brain Tumor Foundation, the Sontag Foundation, the Yuvaan Tiwari Foundation, and BrightEdge, the venture capital arm of…

Read More

Melodi Health Secures $10.75 Million in Series A Funding and Launches Pivotal ARIA Trial for Innovative Breast Reconstruction Device

Editor05 mins

Melodi Health, a trailblazer in breast reconstruction technology, has achieved two significant milestones: the successful close of a $10.75 million Series A funding round and the commencement of the pivotal “ARIA” investigational device exemption (IDE) trial. The company’s efforts are centered on its groundbreaking device, the Melodi Matrix™, aimed at addressing post-surgical complications in breast…

Read More

Tiimo Secures $1.6M in Funding to Expand Neurodivergent-Focused Solutions

Editor04 mins

Tiimo, the innovative app dedicated to supporting neurodivergent individuals, has announced the successful completion of a $1.6 million funding round. This latest investment elevates Tiimo’s total pre-Series A funding to an impressive $4.8 million. Founded in 2016 and headquartered in Copenhagen, Tiimo was developed to cater specifically to those with cognitive differences such as ADHD,…

Read More

Tilt Secures $15 Million Series B Funding to Accelerate HR Tech Innovations

Editor05 mins

Tilt, a trailblazer in leave management solutions, proudly announces the completion of a $15 million Series B funding round, spearheaded by Bramalea Partners. This significant investment also saw contributions from HearstLab, alongside continued backing from Firework Ventures, Origin Ventures, and Techstars. In addition to the funding, Tilt is delighted to welcome Jill Frankle to its…

Read More

PCORI Unveils $165 Million Investment in Groundbreaking Patient-Centered Health Research

Editor06 mins

In a transformative move for the health research sector, the Patient-Centered Outcomes Research Institute (PCORI) has announced a substantial funding commitment of over $165 million. This latest allocation supports a range of new comparative clinical effectiveness research (CER) projects designed to provide invaluable insights into patient care and treatment options. Among the awarded grants, notable…

Read More
From left, Christy McCaig (Nine Realms), Danielle Walsh (Clearly), Katharina Neisinger (Pace Ventures). Photo by Hubert Cecil

Clearly Secures €3.9 Million to Propel Net Zero Carbon Emissions Goals in Transportation and Supply Chains

Editor06 mins

In a significant boost for climate technology, London-based climate intelligence platform Clearly has successfully concluded a €3.9 million seed funding round. This pivotal investment, spearheaded by Pace Ventures and Nine Realms, also welcomed contributions from existing mobility investors Mobilion, Next Gear, and M1720, alongside distinguished angel investors Lord Nash and Margaux Primat. The newly acquired…

Read More

Halda Therapeutics Garners $126 Million in Series B Extension to Propel Innovative Cancer Treatments into Clinical Trials

Editor06 mins

Halda Therapeutics, a leading biotechnology firm renowned for its pioneering cancer therapies, has successfully raised $126 million in a Series B extension. This latest funding round saw significant participation from premier investors, including Deep Track Capital, Frazier Life Sciences, RA Capital Management, Vida Ventures, Boxer Capital, and Taiho Ventures. Existing backers such as Canaan Partners,…

Read More
Founders Floris Engelhardt, John Vroom, Mark Bathe

Kano Therapeutics Secures $7.1 Million in Funding to Revolutionize Genetic Medicine with Non-Viral DNA Insertion

Editor05 mins

Kano Therapeutics, a forward-thinking biotechnology firm emerging from MIT, has announced the successful closure of a $7.1 million funding round, underscoring its potential to reshape the landscape of genetic medicine. This financing includes an oversubscribed $5 million seed round co-led by The Engine Ventures and VSquared Ventures, with additional support from Taihill Venture and Metaplanet….

Read More